C07D 209/04
Indoles
Official title: Indoles; Hydrogenated indoles
C07D209/04 (Indoles) appears on 7,235 US grants and 6,900 published applications in this corpus.
Search patents in C07D- Granted patents
- 7,235
- Published applications
- 6,900
- Assignees
- 2,694
- Inventors
- 19,373
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 82 | 0 |
| 1977 | 68 | 0 |
| 1978 | 82 | 0 |
| 1979 | 62 | 0 |
| 1980 | 69 | 0 |
| 1981 | 60 | 0 |
| 1982 | 53 | 0 |
| 1983 | 61 | 0 |
| 1984 | 93 | 0 |
| 1985 | 66 | 0 |
| 1986 | 87 | 0 |
| 1987 | 86 | 0 |
| 1988 | 68 | 0 |
| 1989 | 120 | 0 |
| 1990 | 92 | 0 |
| 1991 | 81 | 0 |
| 1992 | 99 | 0 |
| 1993 | 127 | 0 |
| 1994 | 92 | 0 |
| 1995 | 94 | 0 |
| 1996 | 132 | 0 |
| 1997 | 154 | 0 |
| 1998 | 157 | 0 |
| 1999 | 154 | 0 |
| 2000 | 148 | 0 |
| 2001 | 195 | 36 |
| 2002 | 176 | 193 |
| 2003 | 174 | 335 |
| 2004 | 176 | 385 |
| 2005 | 161 | 361 |
| 2006 | 212 | 329 |
| 2007 | 201 | 334 |
| 2008 | 190 | 325 |
| 2009 | 209 | 332 |
| 2010 | 245 | 341 |
| 2011 | 188 | 275 |
| 2012 | 203 | 206 |
| 2013 | 185 | 248 |
| 2014 | 214 | 236 |
| 2015 | 194 | 272 |
| 2016 | 200 | 256 |
| 2017 | 231 | 263 |
| 2018 | 181 | 225 |
| 2019 | 207 | 230 |
| 2020 | 179 | 240 |
| 2021 | 161 | 210 |
| 2022 | 155 | 244 |
| 2023 | 158 | 312 |
| 2024 | 173 | 296 |
| 2025 | 156 | 221 |
| 2026 | 124 | 195 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07D 209/10With substituted hydrocarbon radicals attached to carbon atoms of the hetero ring3,692
- C07D 209/30With hetero atoms or with carbon atoms having three bonds to hetero2,672
- C07D 209/08With only hydrogen atoms or radicals containing only hydrogen and carbon atoms2,194
- C07D 209/06Preparation of indole from coal-tar10
- C07D 209/43With an —och2chch2nh2 radical, which may be further substituted, attached in positions1
Recent patents
- Substituted indole compounds and the use thereof6 Oct 2026US 12,753,154 B2Trobio Therapeutics Pty Ltd
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Inhibitors of tyrosine kinase22 Sep 2026US 12,740,982 B2BridGene Biosciences, Inc.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt)8 Oct 2026US 2026/0308121 A1Gh Research Ireland Limited
- Bicyclic inhibitors of cbx chromodomains8 Oct 2026US 2026/0308130 A1Icahn School of Medicine at Mount Sinai
- Fused pyrrolidine-2-one herbicidal compounds1 Oct 2026US 2026/0293894 A1Syngenta Crop Protection AG
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
Most cited
By later US patents
- Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them565US 5,514,718 AMerck Sharp & Dohme Corp. · 1996
- System and methods for nucleic acid sequencing of single molecules by polymerase synthesis410US 6,255,083 B12001
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- 3-heteroaryl-2-indolinone compounds for the treatment of disease265US 5,792,783 ASugen, Inc. · 1998
- Fluorescent indicator dyes for calcium ions238US 4,603,209 AThe Regents of the University of California · 1986